Industry Perspective - What does Industry Need to Accelerate Drug Product and Process Development?

被引：1
|
作者：
Chatterjee, Bikash [1 ]
Steiner, Richard [1 ]
Kaul, Goldi [2 ]
机构：
[1] Pharmatech Associates USP Co, Hayward, CA 94541 USA
[2] Boehringer Ingelheim Pharmaceut, External Alternat CMC Dev, Ridgefield, CT USA
来源：
PHARMACEUTICAL RESEARCH | 2024年 / 41卷 / 01期
基金：
美国国家科学基金会;
关键词：
accelerating; ASAP testing; bayesian; continuous manufacturing; data; drug substance; in-silico modeling; modeling;
D O I：
10.1007/s11095-023-03604-y
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
[No abstract available]
引用
收藏
页码：7 / 11
页数：5
相关论文
共 50 条
  • [21] Product liability: An industry perspective
    Jose-Sebastian, MLA
    [J]. DRUG SAFETY, 2005, 28 (10) : 958 - 958
  • [22] Opportunities Assessment of Product Development Process in Industry 4.0
    Santos, Kassio
    Loures, Eduardo
    Piechnicki, Flavio
    Canciglieri, Osiris
    [J]. 27TH INTERNATIONAL CONFERENCE ON FLEXIBLE AUTOMATION AND INTELLIGENT MANUFACTURING, FAIM2017, 2017, 11 : 1358 - 1365
  • [23] WHAT DOES INDUSTRY NEED - A BUSINESS LOOK AT ENGINEERING-EDUCATION
    GARRY, FW
    [J]. ENGINEERING EDUCATION, 1986, 76 (04): : 203 - 205
  • [24] An industry perspective on current QSP trends in drug development
    Cucurull-Sanchez, Lourdes
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2024,
  • [25] AQUACULTURE DRUG DEVELOPMENT - A PHARMACEUTICAL-INDUSTRY PERSPECTIVE
    BELEAU, MH
    [J]. VETERINARY AND HUMAN TOXICOLOGY, 1991, 33 : 11 - 13
  • [26] An industry statistician's perspective on PHC drug development
    Fridlyand, Jane
    Yeh, Ru-Fang
    Mackey, Howard
    Bengtsson, Thomas
    Delmar, Paul
    Spaniolo, Greg
    Lieberman, Grazyna
    [J]. CONTEMPORARY CLINICAL TRIALS, 2013, 36 (02) : 624 - 635
  • [27] Radiopharmaceuticals for Oncology Drug Development: A Pharmaceutical Industry Perspective
    Murphy, Philip S.
    Bergstrom, Mats
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (09) : 957 - 965
  • [28] Industry Perspective of Drug Development for Pregnant/Breastfeeding Women
    Korth-Bradley, J. M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (01) : 19 - 21
  • [29] Maternal-Fetal Drug Development: An Industry Perspective
    Burnham, Janelle
    Darsey, Edress
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 : S18 - S29
  • [30] Pharmaceutical industry perspective on MPS technologies for drug development
    Gan, Jinping
    [J]. DRUG METABOLISM REVIEWS, 2016, 48 : 20 - 20
12345